Omalizumab Reduced Inhaled Corticosteroid Use and Exacerbations in Childhood Allergic Asthma

Evidence-Based Medicine - United Kingdom
doi 10.1136/ebm.7.1.12
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

BMJ

Related search

Reduced Asthma Exacerbations and Asthma-Related Healthcare Resource Use With Omalizumab From the Real-World PROSPERO Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Relationship of Inhaled Corticosteroid Adherence to Asthma Exacerbations in Patients With Moderate to Severe Asthma

Journal of Allergy and Clinical Immunology: In Practice
AllergyImmunology
2018English

Inhaled Corticosteroid Dose Response in Asthma

Annals of Allergy, Asthma and Immunology
Respiratory MedicinePulmonaryAllergyImmunology
2017English

Inhaled Corticosteroid Use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study

Lung
PulmonaryRespiratory Medicine
2017English

Inhaled Corticosteroid Use Is Associated With Increased Circulating Tregulatory Cells in Children With Asthma

Clinical and Molecular Allergy
AllergyImmunologyMolecular Biology
2013English

Managing Childhood Asthma: Challenge of Preventing Exacerbations

Pediatrics
Child HealthPediatricsPerinatology
2009English

Selectivity and Specificity Are the Keys to Cost-Effective Use of Omalizumab for Allergic Asthma

Journal of Managed Care Pharmacy
2005English

Inhaled Corticosteroid Dose-Response on Blood Eosinophils in Asthma – Authors' Reply

Lancet Respiratory Medicine,The
PulmonaryRespiratory Medicine
2016English

Effects of Omalizumab on Blood Eosinophil Numbers in Patients With Allergic Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy